Sector News

Monsanto misses estimates, no longer eyeing M&A

April 7, 2016
Chemical Value Chain

Monsanto missed estimates for its fiscal second quarter as continued weakness in agriculture markets forced the leading seed manufacturer to cut prices.

Monsanto chairman and CEO Hugh Grant also indicated during an earnings conference call this morning that he no longer sees large-scale mergers and acquisitions as a “likely strategy.” There had been speculation that Monsanto was eying the ag assets of BASF or Bayer, as well as a renewed bid for Syngenta, amid significant agchems consolidation that included ChemChina’s $43.3-billion bid for Syngenta and the Dow Chemical–DuPont merger.

“We believe the industry will continue to rationalize, focusing investment to the highest return options We now see this translating into further R&D or commercial partnerships for which we’re uniquely positioned to participate and no longer see large-scale M&A as a likely opportunity,” Grant says. “Let me be clear. Our strategy is not and was not dependent on large-scale M&A. Rather, our strategy is innovation-driven and it’s highly collaborative.”

Monsanto reports net income of $1.06 billion for the quarter ended 29 February 2016, down 25.3% year-on-year (YOY) Adjusted earnings of $2.42/share was 16.6% lower YOY and 2 cts below the analysts consensus estimate, as reported by Thomson Reuters (New York). Sales were down 12.8% YOY, to $4.5 billion.

“The positive drivers in the quarter, namely the benefits of the company’s reduced share count, Brazil corn pricing, increased Intacta RR2 PRO™ soybean adoption and reduced operating expenses, were offset by glyphosate declines in the Agricultural Productivity segment, increased discounting in the United States in corn and soybeans, lower soybean volumes with the slower start to the U.S. season and expected lower acres, as well as higher corn cost of goods sold resulting from smaller production plans in the prior year,” Monsanto says.

Seeds and genomics gross profit slipped 9.3% YOY, to $2.4 billion, on sales down 8.6%, to $3.8 billion. Corn and soybean sales were down 7.7% and 11.4% YOY, respectively. Agricultural productivity gross profit was down 53.0%, on sales down 29.8%, to $715 million.

Monsanto raised its 2016 earnings guidance from 3.42-4.29/share to $3.72-$4.48/share, primarily due to a change in timing for a restructuring expense. The outlook for ongoing earnings continues to be in the $4.40-$5.10 range.

By Rebecca Coons

Source: Chemical Week

comments closed

Related News

September 17, 2022

Huhtamaki and Stora Enso collaborate on new paper cup recycling initiative

Chemical Value Chain

Huhtamaki and Stora Enso have joined forces to create a new paper cup recycling initiative, The Cup Collective. The programme aims to recycle and capture the value of used paper cups on an industrial scale. The programme will initially be implemented across Belgium, the Netherlands and Luxembourg.

September 17, 2022

Methanex announces new President & CEO effective January 1, 2023

Chemical Value Chain

The Board of Directors of Methanex Corporation announced that John Floren will retire as President and CEO and from the Board as of December 31, 2022. The Board has appointed Rich Sumner as President & Chief Executive Officer and member of the Board of Directors, effective January 1, 2023.

September 17, 2022

Evonik is driving growth through innovations, announces new CIO

Chemical Value Chain

Evonik’s new chief innovation officer, Ralph Marquardt, aims to strengthen the company’s innovative strength even further in the future. Marquardt, who has a doctorate in chemistry and joined Evonik in 2006, has acquired the necessary experience, for example, through leadership roles in various business areas. Sustainability is his central focus.